Top-News

BeOne Medicines Aktie (ADR) News

Aktie
WKN:  A1437N ISIN:  US07725L1026 US-Symbol:  ONC Branche:  Biotechnologie Land:  Schweiz
276,00 €
-6,00 €
-2,13%
15:47:36 Uhr
Depot/Watchlist
Marktkapitalisierung *
34,37 Mrd. €
Streubesitz
46,59%
KGV
-30,43
Faktor
0.0769231
Originalaktie
CH1391448177
Weiter aufwärts? Long handeln - Jetzt mit Hebel 16,33: MM423X
Werbung

BeOne Medicines Aktie (ADR) News

07.02.25 - PR Newswire
Oncolytics Biotech® Announces Matt Coffey, Ph.D. Will Not Return to CEO Role Following Medical Leave of Absence
Oncolytics Biotech® Announces Matt Coffey, Ph.D. Will Not Return to CEO Role Following Medical Leave of Absence PR Newswire
02.02.25 - Börse-Global
BeiGene Aktie: Erfolgsgeheimnis gelüftet
Die BeiGene-​Aktie zeigt zu Beginn des Jahres 2025 eine bemerkenswerte Dynamik an den Börsen. Mit einer aktuellen Marktkapitalisierung von 21,2 Milliarden Euro verzeichnete ...
22.01.25 - PR Newswire
Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium
Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium PR Newswire
22.01.25 - PR Newswire
Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium
Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium PR Newswire
22.01.25 - PR Newswire
Oncolytics Biotech® to Present Compelling New Efficacy and Safety Data in Anal and Pancreatic Cancers at 2025 ASCO GI Symposium
Oncolytics Biotech® to Present Compelling New Efficacy and Safety Data in Anal and Pancreatic Cancers at 2025 ASCO GI Symposium PR Newswire
15.01.25 - PR Newswire
Regulatory Approval Clears Path for Oncolytics Biotech® to Advance Promising Pancreatic Cancer Treatment, Following a Review of Safety Data
Regulatory Approval Clears Path for Oncolytics Biotech® to Advance Promising Pancreatic Cancer Treatment, Following a Review of Safety Data PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr +0,03%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »